Expansion momentum Hikma is actively expanding operations in multiple regions including Bedford in the UK and Ohio in the US, signaling growing capacity and localized supply to support more hospital and pharmacy partners with generic, specialty and branded products.

US manufacturing investment Significant capital deployment in Ohio plants and related job creation as part of a broader $1 billion U.S. expansion, presenting an opportunity to align with regional healthcare providers and distributors seeking consistent supply and competitive pricing.

Product diversification Portfolio covers over 825 generic, specialty and branded medicines across North America, MENA and Europe, offering cross-border sales potential and partnerships for co-development, licensing, or distribution agreements.

Strategic partnerships Active participation in high-profile industry events such as AMNC and Oncology Forum, alongside sponsorships with Guardant Health, indicating openness to collaboration with healthcare tech, diagnostics, and oncology-focused partners.

Regulatory and data readiness ISO/IEC 27001 and SAP-driven operations suggest robust compliance and traceability capabilities, enabling sales conversations around GMP quality, supply integrity, and streamlined procurement for hospitals and distributors.